Click on the session name for more details about the session

Friday, March 10, 2023

TimePlenary Hall
10:00 AM - 10:25 AM Industry Symposium by Novo NordiskRefixia®: A State of the Art, Extended Half-Life rFIX for the Management of Haemophilia B
10:25 AM - 10:50 AM Industry Symposium by BMSIneffective erythropoiesis as a driver for chronic anemias
10:50 AM - 11:15 AM Industry Symposium by EmmausSickle Cell Disease Management Updates
11:15 AM - 11:40 AM Industry Symposium by CSL ViforHow to create an Ironwoman: Real world issues in Iron Deficiency Anemia
11:40 AM - 12:05 PM Industry Symposium by by AstellasBe Ready for R/R AML FLT3 m+ (View from A Clinic)
12:05 PM - 01:45 PM Lunch Break & Friday Prayer
01:45 PM - 02:05 PM Industry Symposium by TakedaOverview of SID: Approaches to Diagnosing and Managing Secondary Immunodeficiency
02:05 PM - 02:30 PM Industry Symposium by SandozRixathon ( Rituxmab by Sandoz) Totality of evidence: from Concept to Reality
02:30 PM - 03:00 PM Industry Symposium by JanssenA New Era of Treatment Freedom in CLL
03:00 PM - 03:10 PM Coffee Break 1
03:10 PM - 03:30 PM Opening Ceremony
03:30 PM - 05:05 PM Session 1: Hemostasis & Thrombosis
05:05 PM - 05:30 PM Industry Symposium by AmgenNovel approaches in MM
05:30 PM - 06:40 PM Session 2: Nursing WorkshopUpdates in the Management of Hematological disorders
06:40 PM - 07:05 PM Industry Symposium by RocheDLBCL 2023: Where do we stand?

Saturday, March 11, 2023

TimePlenary Hall
08:30 AM - 09:30 AM Session 3: Abstracts Session
09:30 AM - 11:00 AM Session 4: Myeloma
11:00 AM - 11:15 AM Coffee Break 2
11:15 AM - 12:05 PM Session 5: Survivorship
12:05 PM - 12:30 PM Industry Symposium by LillyIndolent lymphoproliferative disease
12:30 PM - 02:00 PM Session 6: Lymphoproliferative disorders (I)
02:00 PM - 02:50 PM Lunch Break 2
02:50 PM - 03:15 PM Industry Symposium by AbbvieUnmet Needs in RR DLBCL
03:15 PM - 05:40 PM Session 7: Lymphoproliferative disorders (II)
05:40 PM - 05:55 PM Session 8High Dose Methotrexate Toxicity Management
05:55 PM - 06:20 PM Perspectives in Haemophilia A management: recent results from Efanesoctocog alfa trialsUpdates in Hemphilia A management: recent clinical data from Efanesoctocog alfa

Sunday, March 12, 2023

TimePlenary HallWorkshop Room
08:30 AM - 09:45 AM Session 9: Leukemias (I)
09:45 AM - 10:00 AM Coffee Break 3
10:00 AM - 11:15 AM Session 10: Leukemias (II)
11:15 AM - 11:40 AM Industry Symposium by NovartisSTAMPing out CML
11:40 AM - 12:00 PM Industry Symposium by AstraZeneca(Panel Discussion) - Covid 19 - evolution.. What have we learned so far - Does the new Normal apply to all?
12:00 PM - 12:25 PM Industry Symposium by Sobi 2The use of TPO-RAs in ITP: Not all patients are the same
12:25 PM - 12:50 PM Session 11AI in Hematology
12:50 PM - 02:30 PM Session 12: Myeloproliferative neoplasms
02:30 PM - 02:55 PM Industry Symposium by ServierHow to Treat IDH1 Mutant AML at Diagnosis and R/R Settings
02:30 PM - 05:00 PM Workshop : Elevate the management of CLL
02:55 PM - 03:00 PM Closing Remarks
*The scientific program is subject to change.